Novel compositions for reducing Abeta 42 production and their use in treating Alzheimer's Disease (AD)

Details for Australian Patent Application No. 2011208357 (hide)

Owner Kareus Therapeutics SA

Inventors Akella, Venkateswarulu; Saxena, Uday; Kallam, Anji Reddy

Agent Acumen Intellectual Property

Pub. Number AU-A-2011208357

PCT Pub. Number WO2011/089576

Priority 61/395,702 17.05.10 US; 198/MUM/2010 25.01.10 IN

Filing date 22 January 2011

Wipo publication date 28 July 2011

International Classifications

C07D 213/80 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4406 - only substituted in position 3, e.g. zimeldine

A61P 25/28 Drugs for disorders of the nervous system

C07D 213/82 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/089576 Priority application(s): WO2011/089576

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011208363-Process to make biodegradable a synthetic polymer

2011208346-Integrated remote pollution monitoring and indexing system and method thereof